Skip to main content

Funding Opportunities

We offer an array of funding opportunities that support our mission of turning research observations into health solutions through translational science.

Open Funding Opportunities

Find an open funding opportunity using the search tool. The expiration date currently displayed is the final expiration date.

Learn more about the NIH clinical trial requirements for grants and contracts.

If you are looking for closed opportunities, visit grants.nih.gov.

Investigators may apply for NIH-funded scientific conference grants to support high-quality national and international meetings that are relevant to public health and our mission. See NIH’s frequently asked questions for more information.

Name NCATS Issued FOA Number Activity Code Posting Date Expiration Date Opportunity Type
Notice Clarifying SBIR Direct-to-Phase II Eligibility Criteria NOT-OD-16-052 01/12/2016 Policy Notice
Notice of Participation of NCATS in RFA-HL-14-012 Small Market Awards: SBIR Phase IIB Competing Renewals for Heart, Lung, Blood and Sleep Technologies with Small Commercial Markets (R44) NOT-TR-13-006 04/15/2013 NA
Notice of Special Interest (NOSI): Small Business Initiatives for Innovative tools and Technologies for Improving Outcomes for Maternal Health NOT-EB-23-005 U44, R43/R44, R41/R42 07/26/2023 09/08/2025 Notice of Special Interest
Industrialization and Translation of Extracellular Vesicles for use in Regenerative Medicine (U43/U44 Clinical Trials Not Allowed) PAR-23-267 U43/U44 04/18/2023 10/06/2025 NA
Notice of Special Interest (NOSI): Small Business Initiatives for Innovative tools and Technologies for Improving Outcomes for Maternal Health NOT-EB-23-005 U44, R43/R44, R41/R42 07/26/2023 09/08/2025 Notice of Special Interest
Industrialization and Translation of Extracellular Vesicles for use in Regenerative Medicine (UT1/UT2) Clinical Trial Not Allowed PAR-23-268 UT1 04/18/2023 10/06/2025 NA
HEAL Initiative: Notice of Interest in Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Applications Directed at Enhanced Pain Management and Improved Treatments for Opioid Misuse and Addiction NOT-NS-19-014 12/10/2018 NA
Reinstatement of NIH SBIR Direct-to-Phase II Authority and Associated Updates to NCATS Platform Delivery Technologies for Nucleic Acid Therapeutics (R43/R44) Funding Opportunity Announcement NOT-TR-19-004 10/15/2018 NA
Showing Row 11 to 18 of 18

Last updated on February 19, 2025